Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease.
about
Toxicities of immunosuppressive treatment of autoimmune neurologic diseases.Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial.Metastatic hepatocellular carcinoma in a patient with Crohn's disease treated with azathioprine and infliximab: a case report and literature reviewMedical conditions and risk of adult myeloid leukemia.Development of a cost-effective high-throughput process of microsatellite analysis involving miniaturized multiplexed PCR amplification and automated allele identification.Thiopurines related malignancies in inflammatory bowel disease: local experience in Granada, Spain.9-Benzyl-6-benzyl-sulfanyl-9H-purin-2-amine.Diagnosis and treatment of lupus nephritis flares--an update.Review article: antitumoural immunity in colorectal cancer - current and potential future implications in clinical practice.Does a personal or family history of malignancy preclude the use of immunomodulators and biologics in IBD.Toxicity and response to thiopurines in patients with inflammatory bowel disease.Oxidatively-generated damage to DNA and proteins mediated by photosensitized UVAKaposi Sarcoma Mimicking Acute Flare of Ulcerative Colitis.Understanding the Cautions and Contraindications of Immunomodulator and Biologic Therapies for Use in Inflammatory Bowel Disease.Iatrogenic immunosuppression and risk of non-Hodgkin lymphoma in solid organ transplantation: A population-based cohort study in Australia.Mutagenicity monitoring following battlefield exposures: Molecular analysis of HPRT mutations in Gulf War I veterans exposed to depleted uranium.Drug therapies and the risk of malignancy in Crohn's disease: results from the TREAT™ Registry.Use of azathioprine and the risk of cancer in inflammatory bowel disease.Risk of melanoma and non-melanoma skin cancer in ulcerative colitis patients treated with thiopurines: a nationwide retrospective cohort.
P2860
Q34257903-1BA2EA15-5E4D-489E-9970-41333D8EF07AQ34409787-72FAF397-F6D4-4E8E-BABC-A4B88295243FQ34814602-5DF02143-9180-43FB-91DE-36449A20CC1AQ36608364-D76712C6-3195-4BFC-8702-9A711E130D21Q36693677-6CB8CC36-4DDD-4676-AA8E-F6CFA8276DB4Q37087479-5AA773FC-3ECD-4A45-B13E-009EF3890267Q37721238-C5750C84-8129-4C22-988C-1B04635F9B81Q38059445-C057717D-8EB7-44B3-8D79-57F2A6FFD0DAQ38108366-0B2985B8-A6FF-4E7C-ABAA-44692870A815Q38253832-7BE8575D-2C6E-430D-ABBC-94FEADCDADFCQ38443981-8767EB9C-3264-4445-BA57-6121F8028F7DQ39042732-C54E2C37-8EC2-4170-951D-3A348C2CEEC8Q39389758-789E2E5C-B323-414B-ACE3-DD3CCB8D271EQ39435409-1F943A85-14D2-4B91-982F-3B5B5AE3A9D8Q39803518-D43BD9CA-C427-4B2D-B454-7FCA5D9191C4Q41011479-E98963D8-F91C-4DEA-9503-666C74EC08C1Q43778384-136F3D7C-B9C0-47C0-83AB-BC1B492B136BQ45132140-CB40D110-A20E-4EE4-9ED8-428215FDCB8BQ45943688-037ADB77-E91E-4647-8D9A-EE8AB5AB729E
P2860
Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mutagenicity and potential car ...... th inflammatory bowel disease.
@en
Mutagenicity and potential car ...... th inflammatory bowel disease.
@nl
type
label
Mutagenicity and potential car ...... th inflammatory bowel disease.
@en
Mutagenicity and potential car ...... th inflammatory bowel disease.
@nl
prefLabel
Mutagenicity and potential car ...... th inflammatory bowel disease.
@en
Mutagenicity and potential car ...... th inflammatory bowel disease.
@nl
P2093
P2860
P1433
P1476
Mutagenicity and potential car ...... th inflammatory bowel disease.
@en
P2093
Barry A Finette
Pamela M Vacek
Patrick O'Neill
Richard B Colletti
Truc Nguyen
P2860
P304
P356
10.1158/0008-5472.CAN-09-0451
P407
P577
2009-08-25T00:00:00Z